APO Research
Talk to an analyst

APO RESEARCH · REPORT

Taxifolin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Taxifolin Market Outlook and Growth Opportunities 2026

19 December 2025190 pages

Choose your research edition.

Industry ResearchTaxifolin Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Taxifolin Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Taxifolin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Taxifolin Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Taxifolin Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Taxifolin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Taxifolin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Taxifolin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Taxifolin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Taxifolin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Taxifolin market include Ametis JSC, JW Health Products, Kalenika Group, Hefei Lifeon Pharma, ROBIOS, Kingherbs Ltd, Beton Nutrition Corporation and Xi'an Sost Biotech Co.,Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Taxifolin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Taxifolin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Taxifolin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Taxifolin market size, projected growth trends, production technologies, key applications, and end-use industries.

Taxifolin Segment by Company

Ametis JSC

JW Health Products

Kalenika Group

Hefei Lifeon Pharma

ROBIOS

Kingherbs Ltd

Beton Nutrition Corporation

Xi'an Sost Biotech Co.,Ltd

Taxifolin Segment by Type

Below 92%

92%-98%

Above 98%

Taxifolin Segment by Application

Food and Beverages

Healthcare

Cosmetics

Agriculture

Others

Taxifolin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Taxifolin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Taxifolin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Taxifolin significant trends, drivers, influence factors in global and regions.

6. To analyze Taxifolin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Taxifolin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Taxifolin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Taxifolin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Taxifolin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Taxifolin industry.

Chapter 3: Detailed analysis of Taxifolin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Taxifolin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Taxifolin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Taxifolin Industry Trends Table 2. Taxifolin Industry Drivers Table 3. Taxifolin Industry Opportunities and Challenges Table 4. Taxifolin Industry Restraints Table 5. Global Taxifolin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Taxifolin Revenue Share by Company (2021-2026) Table 7. Global Taxifolin Sales Volume by Company (KG) & (2021-2026) Table 8. Global Taxifolin Sales Volume Share by Company (2021-2026) Table 9. Global Taxifolin Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Taxifolin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Taxifolin Key Company Manufacturing Base & Headquarters Table 12. Global Taxifolin Company, Product Type & Application Table 13. Global Taxifolin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Taxifolin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Below 92% Table 18. Significant Companies of 92%-98% Table 19. Significant Companies of Above 98% Table 20. Global Taxifolin Sales Volume by Type 2021 VS 2025 VS 2032 (KG) Table 21. Global Taxifolin Sales Volume by Type (2021-2026) & (KG) Table 22. Global Taxifolin Sales Volume by Type (2027-2032) & (KG) Table 23. Global Taxifolin Sales Volume Share by Type (2021-2026) Table 24. Global Taxifolin Sales Volume Share by Type (2027-2032) Table 25. Global Taxifolin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Taxifolin Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Taxifolin Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Taxifolin Sales Value Share by Type (2021-2026) Table 29. Global Taxifolin Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Food and Beverages Table 31. Significant Companies of Healthcare Table 32. Significant Companies of Cosmetics Table 33. Significant Companies of Agriculture Table 34. Significant Companies of Others Table 35. Global Taxifolin Sales Volume by Application 2021 VS 2025 VS 2032 (KG) Table 36. Global Taxifolin Sales Volume by Application (2021-2026) & (KG) Table 37. Global Taxifolin Sales Volume by Application (2027-2032) & (KG) Table 38. Global Taxifolin Sales Volume Share by Application (2021-2026) Table 39. Global Taxifolin Sales Volume Share by Application (2027-2032) Table 40. Global Taxifolin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Taxifolin Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Taxifolin Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Taxifolin Sales Value Share by Application (2021-2026) Table 44. Global Taxifolin Sales Value Share by Application (2027-2032) Table 45. Global Taxifolin Sales by Region: 2021 VS 2025 VS 2032 (KG) Table 46. Global Taxifolin Sales by Region (2021-2026) & (KG) Table 47. Global Taxifolin Sales Market Share by Region (2021-2026) Table 48. Global Taxifolin Sales by Region (2027-2032) & (KG) Table 49. Global Taxifolin Sales Market Share by Region (2027-2032) Table 50. Global Taxifolin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Taxifolin Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Taxifolin Sales Value Share by Region (2021-2026) Table 53. Global Taxifolin Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Taxifolin Sales Value Share by Region (2027-2032) Table 55. Global Taxifolin Market Average Price (US$/Ton) by Region (2021-2026) Table 56. Global Taxifolin Market Average Price (US$/Ton) by Region (2027-2032) Table 57. Global Taxifolin Sales by Country: 2021 VS 2025 VS 2032 (KG) Table 58. Global Taxifolin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Taxifolin Sales by Country (2021-2026) & (KG) Table 60. Global Taxifolin Sales Market Share by Country (2021-2026) Table 61. Global Taxifolin Sales by Country (2027-2032) & (KG) Table 62. Global Taxifolin Sales Market Share by Country (2027-2032) Table 63. Global Taxifolin Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Taxifolin Sales Value Market Share by Country (2021-2026) Table 65. Global Taxifolin Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Taxifolin Sales Value Market Share by Country (2027-2032) Table 67. Ametis JSC Company Information Table 68. Ametis JSC Business Overview Table 69. Ametis JSC Taxifolin Sales (KG), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Ametis JSC Taxifolin Product Portfolio Table 71. Ametis JSC Recent Development Table 72. JW Health Products Company Information Table 73. JW Health Products Business Overview Table 74. JW Health Products Taxifolin Sales (KG), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. JW Health Products Taxifolin Product Portfolio Table 76. JW Health Products Recent Development Table 77. Kalenika Group Company Information Table 78. Kalenika Group Business Overview Table 79. Kalenika Group Taxifolin Sales (KG), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Kalenika Group Taxifolin Product Portfolio Table 81. Kalenika Group Recent Development Table 82. Hefei Lifeon Pharma Company Information Table 83. Hefei Lifeon Pharma Business Overview Table 84. Hefei Lifeon Pharma Taxifolin Sales (KG), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Hefei Lifeon Pharma Taxifolin Product Portfolio Table 86. Hefei Lifeon Pharma Recent Development Table 87. ROBIOS Company Information Table 88. ROBIOS Business Overview Table 89. ROBIOS Taxifolin Sales (KG), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. ROBIOS Taxifolin Product Portfolio Table 91. ROBIOS Recent Development Table 92. Kingherbs Ltd Company Information Table 93. Kingherbs Ltd Business Overview Table 94. Kingherbs Ltd Taxifolin Sales (KG), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Kingherbs Ltd Taxifolin Product Portfolio Table 96. Kingherbs Ltd Recent Development Table 97. Beton Nutrition Corporation Company Information Table 98. Beton Nutrition Corporation Business Overview Table 99. Beton Nutrition Corporation Taxifolin Sales (KG), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Beton Nutrition Corporation Taxifolin Product Portfolio Table 101. Beton Nutrition Corporation Recent Development Table 102. Xi'an Sost Biotech Co.,Ltd Company Information Table 103. Xi'an Sost Biotech Co.,Ltd Business Overview Table 104. Xi'an Sost Biotech Co.,Ltd Taxifolin Sales (KG), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Xi'an Sost Biotech Co.,Ltd Taxifolin Product Portfolio Table 106. Xi'an Sost Biotech Co.,Ltd Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Taxifolin Distributors List Table 110. Taxifolin Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Taxifolin Product Image Figure 2. Global Taxifolin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Taxifolin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Taxifolin Sales (2021-2032) & (KG) Figure 5. Global Taxifolin Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Taxifolin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Below 92% Image Figure 10. 92%-98% Image Figure 11. Above 98% Image Figure 12. Global Taxifolin Sales Volume by Type (2021 VS 2025 VS 2032) & (KG) Figure 13. Global Taxifolin Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Taxifolin Sales Volume Share by Type (2021-2032) Figure 15. Global Taxifolin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Taxifolin Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Taxifolin Sales Value Share by Type (2021-2032) Figure 18. Food and Beverages Image Figure 19. Healthcare Image Figure 20. Cosmetics Image Figure 21. Agriculture Image Figure 22. Others Image Figure 23. Global Taxifolin Sales Volume by Application (2021 VS 2025 VS 2032) & (KG) Figure 24. Global Taxifolin Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Taxifolin Sales Volume Share by Application (2021-2032) Figure 26. Global Taxifolin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Taxifolin Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Taxifolin Sales Value Share by Application (2021-2032) Figure 29. Global Taxifolin Sales by Region: 2021 VS 2025 VS 2032 (KG) Figure 30. Global Taxifolin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Taxifolin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Taxifolin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Taxifolin Sales Value (2021-2032) & (US$ Million) Figure 34. North America Taxifolin Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Taxifolin Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Taxifolin Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Taxifolin Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Taxifolin Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Taxifolin Sales Value (2021-2032) & (US$ Million) Figure 40. South America Taxifolin Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Taxifolin Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Taxifolin Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Taxifolin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Taxifolin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Taxifolin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Taxifolin Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Taxifolin Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Below 92%
  • 92%-98%
  • Above 98%
Applications
  • Food and Beverages
  • Healthcare
  • Cosmetics
  • Agriculture
  • Others
Companies covered
  • Ametis JSC
  • JW Health Products
  • Kalenika Group
  • Hefei Lifeon Pharma
  • ROBIOS
  • Kingherbs Ltd
  • Beton Nutrition Corporation
  • Xi'an Sost Biotech Co.,Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Taxifolin Sales Value (2021-2032)
  4. 1.2.2 Global Taxifolin Sales Volume (2021-2032)
  5. 1.2.3 Global Taxifolin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Taxifolin Market Dynamics
  1. 2.1 Taxifolin Industry Trends
  2. 2.2 Taxifolin Industry Drivers
  3. 2.3 Taxifolin Industry Opportunities and Challenges
  4. 2.4 Taxifolin Industry Restraints
3 Taxifolin Market by Company
  1. 3.1 Global Taxifolin Company Revenue Ranking in 2025
  2. 3.2 Global Taxifolin Revenue by Company (2021-2026)
  3. 3.3 Global Taxifolin Sales Volume by Company (2021-2026)
  4. 3.4 Global Taxifolin Average Price by Company (2021-2026)
  5. 3.5 Global Taxifolin Company Ranking (2024-2026)
  6. 3.6 Global Taxifolin Company Manufacturing Base and Headquarters
  7. 3.7 Global Taxifolin Company Product Type and Application
  8. 3.8 Global Taxifolin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Taxifolin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Taxifolin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Taxifolin Market by Type
  1. 4.1 Taxifolin Type Introduction
  2. 4.1.1 Below 92%
  3. 4.1.2 92%-98%
  4. 4.1.3 Above 98%
  5. 4.2 Global Taxifolin Sales Volume by Type
  6. 4.2.1 Global Taxifolin Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Taxifolin Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Taxifolin Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Taxifolin Sales Value by Type
  10. 4.3.1 Global Taxifolin Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Taxifolin Sales Value by Type (2021-2032)
  12. 4.3.3 Global Taxifolin Sales Value Share by Type (2021-2032)
5 Taxifolin Market by Application
  1. 5.1 Taxifolin Application Introduction
  2. 5.1.1 Food and Beverages
  3. 5.1.2 Healthcare
  4. 5.1.3 Cosmetics
  5. 5.1.4 Agriculture
  6. 5.1.5 Others
  7. 5.2 Global Taxifolin Sales Volume by Application
  8. 5.2.1 Global Taxifolin Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Taxifolin Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Taxifolin Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Taxifolin Sales Value by Application
  12. 5.3.1 Global Taxifolin Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Taxifolin Sales Value by Application (2021-2032)
  14. 5.3.3 Global Taxifolin Sales Value Share by Application (2021-2032)
6 Taxifolin Regional Sales and Value Analysis
  1. 6.1 Global Taxifolin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Taxifolin Sales by Region (2021-2032)
  3. 6.2.1 Global Taxifolin Sales by Region: 2021-2026
  4. 6.2.2 Global Taxifolin Sales by Region (2027-2032)
  5. 6.3 Global Taxifolin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Taxifolin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Taxifolin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Taxifolin Sales Value by Region (2027-2032)
  9. 6.5 Global Taxifolin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Taxifolin Sales Value (2021-2032)
  12. 6.6.2 North America Taxifolin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Taxifolin Sales Value (2021-2032)
  15. 6.7.2 Europe Taxifolin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Taxifolin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Taxifolin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Taxifolin Sales Value (2021-2032)
  21. 6.9.2 South America Taxifolin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Taxifolin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Taxifolin Sales Value Share by Country, 2025 VS 2032
7 Taxifolin Country-level Sales and Value Analysis
  1. 7.1 Global Taxifolin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Taxifolin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Taxifolin Sales by Country (2021-2032)
  4. 7.3.1 Global Taxifolin Sales by Country (2021-2026)
  5. 7.3.2 Global Taxifolin Sales by Country (2027-2032)
  6. 7.4 Global Taxifolin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Taxifolin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Taxifolin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Taxifolin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Taxifolin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Taxifolin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Taxifolin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Taxifolin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Taxifolin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Taxifolin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Taxifolin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Taxifolin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Taxifolin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Taxifolin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Taxifolin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Taxifolin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Taxifolin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Taxifolin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Taxifolin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Taxifolin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Taxifolin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Taxifolin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Taxifolin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Taxifolin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Taxifolin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Taxifolin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Taxifolin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Taxifolin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Taxifolin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Taxifolin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Taxifolin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Taxifolin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Taxifolin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Taxifolin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Taxifolin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Taxifolin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Taxifolin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Taxifolin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Taxifolin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Taxifolin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Taxifolin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Taxifolin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Taxifolin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Taxifolin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Taxifolin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Taxifolin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Taxifolin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Taxifolin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Taxifolin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Taxifolin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Taxifolin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Taxifolin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Taxifolin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Taxifolin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Taxifolin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Taxifolin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Taxifolin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Taxifolin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Taxifolin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Taxifolin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Taxifolin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Taxifolin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Taxifolin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Taxifolin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Taxifolin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Taxifolin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Taxifolin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Taxifolin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Taxifolin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Taxifolin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Taxifolin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Taxifolin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Taxifolin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Taxifolin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Taxifolin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Taxifolin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Taxifolin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Taxifolin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Taxifolin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Taxifolin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Taxifolin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Taxifolin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Taxifolin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Taxifolin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Taxifolin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Taxifolin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Taxifolin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ametis JSC
  2. 8.1.1 Ametis JSC Company Information
  3. 8.1.2 Ametis JSC Business Overview
  4. 8.1.3 Ametis JSC Taxifolin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ametis JSC Taxifolin Product Portfolio
  6. 8.1.5 Ametis JSC Recent Developments
  7. 8.2 JW Health Products
  8. 8.2.1 JW Health Products Company Information
  9. 8.2.2 JW Health Products Business Overview
  10. 8.2.3 JW Health Products Taxifolin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 JW Health Products Taxifolin Product Portfolio
  12. 8.2.5 JW Health Products Recent Developments
  13. 8.3 Kalenika Group
  14. 8.3.1 Kalenika Group Company Information
  15. 8.3.2 Kalenika Group Business Overview
  16. 8.3.3 Kalenika Group Taxifolin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Kalenika Group Taxifolin Product Portfolio
  18. 8.3.5 Kalenika Group Recent Developments
  19. 8.4 Hefei Lifeon Pharma
  20. 8.4.1 Hefei Lifeon Pharma Company Information
  21. 8.4.2 Hefei Lifeon Pharma Business Overview
  22. 8.4.3 Hefei Lifeon Pharma Taxifolin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hefei Lifeon Pharma Taxifolin Product Portfolio
  24. 8.4.5 Hefei Lifeon Pharma Recent Developments
  25. 8.5 ROBIOS
  26. 8.5.1 ROBIOS Company Information
  27. 8.5.2 ROBIOS Business Overview
  28. 8.5.3 ROBIOS Taxifolin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 ROBIOS Taxifolin Product Portfolio
  30. 8.5.5 ROBIOS Recent Developments
  31. 8.6 Kingherbs Ltd
  32. 8.6.1 Kingherbs Ltd Company Information
  33. 8.6.2 Kingherbs Ltd Business Overview
  34. 8.6.3 Kingherbs Ltd Taxifolin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Kingherbs Ltd Taxifolin Product Portfolio
  36. 8.6.5 Kingherbs Ltd Recent Developments
  37. 8.7 Beton Nutrition Corporation
  38. 8.7.1 Beton Nutrition Corporation Company Information
  39. 8.7.2 Beton Nutrition Corporation Business Overview
  40. 8.7.3 Beton Nutrition Corporation Taxifolin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Beton Nutrition Corporation Taxifolin Product Portfolio
  42. 8.7.5 Beton Nutrition Corporation Recent Developments
  43. 8.8 Xi'an Sost Biotech Co.,Ltd
  44. 8.8.1 Xi'an Sost Biotech Co.,Ltd Company Information
  45. 8.8.2 Xi'an Sost Biotech Co.,Ltd Business Overview
  46. 8.8.3 Xi'an Sost Biotech Co.,Ltd Taxifolin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Xi'an Sost Biotech Co.,Ltd Taxifolin Product Portfolio
  48. 8.8.5 Xi'an Sost Biotech Co.,Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Taxifolin Value Chain Analysis
  2. 9.1.1 Taxifolin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Taxifolin Sales Mode & Process
  6. 9.2 Taxifolin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Taxifolin Distributors
  9. 9.2.3 Taxifolin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst